OEC posts healthy third-quarter results

Article

C-arm manufacturer OEC Medical Systems reported strong third-quarter (end-September) results this month. The company posted revenues of $47.9 million, an increase of 23% over $39 million in sales for the same period last year. The quarter’s net

C-arm manufacturer OEC Medical Systems reported strong third-quarter (end-September) results this month. The company posted revenues of $47.9 million, an increase of 23% over $39 million in sales for the same period last year. The quarter’s net income climbed 25%, from $3.4 million to $4.3 million.

Executives with the Salt Lake City firm attributed the strong product demand to the increase in minimally invasive procedures, as well as increasing use by healthcare delivery networks of outpatient procedures.

In other OEC news, the company announced Oct. 16 that Dallas-based supply chain management company Novation awarded OEC a three-year contract, making OEC Novation’s sole-source supplier of mobile C-arms. The deal is estimated at approximately $30 million annually. It includes OEC’s Mini 6600 C-arm and its full-size mobile units Series 9600, 7600, and 7700. The OEC award is Novation’s first capital equipment contract as a new entity, according to OEC.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.